

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.60755750 |
| 2 | vocalization behavior (GO:0071625) | 5.46623263 |
| 3 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.36191544 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.32558453 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.19460832 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.14698024 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.09490679 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.99449877 |
| 9 | glutamate secretion (GO:0014047) | 4.89342216 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.80614196 |
| 11 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.76181646 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.69070605 |
| 13 | protein localization to synapse (GO:0035418) | 4.66164125 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.44969012 |
| 15 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.42989915 |
| 16 | exploration behavior (GO:0035640) | 4.40789083 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.29873392 |
| 18 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.25429157 |
| 19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.24452365 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.17901245 |
| 21 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.15537302 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.08683657 |
| 23 | dopamine biosynthetic process (GO:0042416) | 4.08016454 |
| 24 | regulation of synapse structural plasticity (GO:0051823) | 4.05966434 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 3.99011454 |
| 26 | mating behavior (GO:0007617) | 3.97525683 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 3.95881699 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 3.95072843 |
| 29 | neuron recognition (GO:0008038) | 3.93157702 |
| 30 | neurotransmitter secretion (GO:0007269) | 3.90613853 |
| 31 | proline transport (GO:0015824) | 3.89778903 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 3.81786188 |
| 33 | dopamine transport (GO:0015872) | 3.80068292 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 3.73831280 |
| 35 | postsynaptic membrane organization (GO:0001941) | 3.73103646 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.72790838 |
| 37 | long-term memory (GO:0007616) | 3.72351345 |
| 38 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.70428545 |
| 39 | prepulse inhibition (GO:0060134) | 3.65628706 |
| 40 | axonal fasciculation (GO:0007413) | 3.63620563 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.60078216 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.59284686 |
| 43 | regulation of postsynaptic membrane potential (GO:0060078) | 3.56162111 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.55679418 |
| 45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.54950455 |
| 46 | presynaptic membrane assembly (GO:0097105) | 3.49394026 |
| 47 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.48731786 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.48275885 |
| 49 | cellular potassium ion homeostasis (GO:0030007) | 3.47466865 |
| 50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.47049862 |
| 51 | transmission of nerve impulse (GO:0019226) | 3.44513179 |
| 52 | long-term synaptic potentiation (GO:0060291) | 3.42799022 |
| 53 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.35036471 |
| 54 | catecholamine transport (GO:0051937) | 3.34394218 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.31133701 |
| 56 | regulation of synapse maturation (GO:0090128) | 3.30640915 |
| 57 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.30082821 |
| 58 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28320453 |
| 59 | neurotransmitter transport (GO:0006836) | 3.27077210 |
| 60 | membrane depolarization (GO:0051899) | 3.25428300 |
| 61 | presynaptic membrane organization (GO:0097090) | 3.24991309 |
| 62 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.23810712 |
| 63 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.23161835 |
| 64 | positive regulation of dendritic spine development (GO:0060999) | 3.22229100 |
| 65 | dendrite morphogenesis (GO:0048813) | 3.21595758 |
| 66 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.20166086 |
| 67 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.16704435 |
| 68 | behavioral fear response (GO:0001662) | 3.15271151 |
| 69 | behavioral defense response (GO:0002209) | 3.15271151 |
| 70 | cell communication by electrical coupling (GO:0010644) | 3.14833287 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.14529616 |
| 72 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.13167064 |
| 73 | membrane depolarization during action potential (GO:0086010) | 3.12924013 |
| 74 | membrane assembly (GO:0071709) | 3.12892817 |
| 75 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.11871551 |
| 76 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.11684800 |
| 77 | regulation of vesicle fusion (GO:0031338) | 3.10927170 |
| 78 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.09360490 |
| 79 | regulation of dendritic spine development (GO:0060998) | 3.08472861 |
| 80 | regulation of neurotransmitter transport (GO:0051588) | 3.07256041 |
| 81 | phenol-containing compound catabolic process (GO:0019336) | 3.05936312 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.05866560 |
| 83 | cell migration in hindbrain (GO:0021535) | 3.04919652 |
| 84 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.04368064 |
| 85 | regulation of neurotransmitter levels (GO:0001505) | 3.03055455 |
| 86 | cerebellar granule cell differentiation (GO:0021707) | 3.02748364 |
| 87 | regulation of neurotransmitter secretion (GO:0046928) | 3.01468631 |
| 88 | activation of protein kinase A activity (GO:0034199) | 3.00942996 |
| 89 | sodium ion export (GO:0071436) | 3.00525871 |
| 90 | response to histamine (GO:0034776) | 3.00309579 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99629535 |
| 92 | auditory behavior (GO:0031223) | 2.99018397 |
| 93 | neuromuscular process controlling balance (GO:0050885) | 2.98861996 |
| 94 | learning (GO:0007612) | 2.96580633 |
| 95 | response to cocaine (GO:0042220) | 2.96257190 |
| 96 | response to auditory stimulus (GO:0010996) | 2.95210053 |
| 97 | innervation (GO:0060384) | 2.92174926 |
| 98 | synapse assembly (GO:0007416) | 2.91815887 |
| 99 | fear response (GO:0042596) | 2.90246315 |
| 100 | neuromuscular process controlling posture (GO:0050884) | 2.89133234 |
| 101 | regulation of synaptic transmission (GO:0050804) | 2.88337509 |
| 102 | dendritic spine organization (GO:0097061) | 2.87210090 |
| 103 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.86785851 |
| 104 | long term synaptic depression (GO:0060292) | 2.85852160 |
| 105 | synaptic transmission (GO:0007268) | 2.85777846 |
| 106 | response to gravity (GO:0009629) | 2.84301125 |
| 107 | positive regulation of synaptic transmission (GO:0050806) | 2.84072496 |
| 108 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.82633559 |
| 109 | neuronal ion channel clustering (GO:0045161) | 2.80004188 |
| 110 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.78923492 |
| 111 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.78815958 |
| 112 | L-amino acid import (GO:0043092) | 2.78733674 |
| 113 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.77793295 |
| 114 | membrane hyperpolarization (GO:0060081) | 2.77790021 |
| 115 | amino acid import (GO:0043090) | 2.75553743 |
| 116 | response to amphetamine (GO:0001975) | 2.74995707 |
| 117 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.74362027 |
| 118 | urinary tract smooth muscle contraction (GO:0014848) | 2.74348235 |
| 119 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.72302705 |
| 120 | detection of calcium ion (GO:0005513) | 2.71147303 |
| 121 | regulation of cell communication by electrical coupling (GO:0010649) | 2.70084199 |
| 122 | regulation of catecholamine metabolic process (GO:0042069) | 2.69155076 |
| 123 | regulation of dopamine metabolic process (GO:0042053) | 2.69155076 |
| 124 | dopamine metabolic process (GO:0042417) | 2.63432492 |
| 125 | regulation of ARF protein signal transduction (GO:0032012) | 2.61465694 |
| 126 | response to water (GO:0009415) | 2.60685527 |
| 127 | response to manganese ion (GO:0010042) | 2.60248805 |
| 128 | potassium ion homeostasis (GO:0055075) | 2.56407824 |
| 129 | potassium ion import (GO:0010107) | 2.56102907 |
| 130 | neuromuscular synaptic transmission (GO:0007274) | 2.54190467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.10153188 |
| 2 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.57204977 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14306336 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13118394 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04009993 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.76373228 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.76373228 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66278889 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65751725 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64455592 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58548081 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55060989 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.48974111 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47543777 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47469111 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42946661 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22893082 |
| 18 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20553425 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20354161 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17647747 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.09460912 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03358113 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94769204 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92715672 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89612210 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88186833 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87345478 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82717144 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81184272 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78416281 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76320688 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72199279 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69463791 |
| 34 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59885063 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59658186 |
| 36 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.59507764 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58858742 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57413260 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55721996 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52929341 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.49096215 |
| 42 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49005246 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45758348 |
| 44 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45384844 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.44659570 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44117543 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42335966 |
| 48 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37285317 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37171029 |
| 50 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36860656 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34540628 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32700296 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32511133 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31712637 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30829997 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29380142 |
| 57 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28748473 |
| 58 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28178535 |
| 59 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27460771 |
| 60 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23638608 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22142476 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22110421 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20664077 |
| 64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16730032 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.15894909 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15091308 |
| 67 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.14376658 |
| 68 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.13491553 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11976729 |
| 70 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.11642151 |
| 71 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11183971 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11006979 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10376865 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09817386 |
| 75 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09768776 |
| 76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09632124 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09003674 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08740045 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.08613347 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08302515 |
| 81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08106022 |
| 82 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07779535 |
| 83 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06819645 |
| 84 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.06499732 |
| 85 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06440597 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06262348 |
| 87 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05699079 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05548350 |
| 89 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.05526776 |
| 90 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04825317 |
| 91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03821240 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03090185 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03090185 |
| 94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02605090 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01042144 |
| 96 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99362654 |
| 97 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99090170 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99045853 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98717172 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98338535 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97919711 |
| 102 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97702298 |
| 103 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97702298 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95857372 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94190554 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93646850 |
| 107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93445719 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92919949 |
| 109 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92909271 |
| 110 | JUN_21703547_ChIP-Seq_K562_Human | 0.92291571 |
| 111 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92090102 |
| 112 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91927530 |
| 113 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90571006 |
| 114 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90309523 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90127959 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89618130 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89410274 |
| 118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89129965 |
| 119 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88434986 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88118513 |
| 121 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88079066 |
| 122 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87172096 |
| 123 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86953908 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85484359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.35475286 |
| 2 | MP0003880_abnormal_central_pattern | 5.03119724 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.99294810 |
| 4 | MP0004270_analgesia | 3.37156061 |
| 5 | MP0009745_abnormal_behavioral_response | 3.21317212 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.21005703 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.01488582 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.99755904 |
| 9 | MP0002064_seizures | 2.99375006 |
| 10 | MP0009046_muscle_twitch | 2.93177981 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.75900294 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.73473439 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.54354729 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.51370533 |
| 15 | MP0001486_abnormal_startle_reflex | 2.49404299 |
| 16 | MP0002272_abnormal_nervous_system | 2.45093468 |
| 17 | MP0002736_abnormal_nociception_after | 2.42513395 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.30526640 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.21818012 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.00179940 |
| 21 | MP0002822_catalepsy | 1.98213944 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.98012989 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.93964957 |
| 24 | MP0000778_abnormal_nervous_system | 1.93255263 |
| 25 | MP0001970_abnormal_pain_threshold | 1.88434030 |
| 26 | MP0004858_abnormal_nervous_system | 1.88258246 |
| 27 | MP0003329_amyloid_beta_deposits | 1.87155708 |
| 28 | MP0002184_abnormal_innervation | 1.76678907 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.76011182 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.68917780 |
| 31 | MP0004924_abnormal_behavior | 1.68917780 |
| 32 | MP0008569_lethality_at_weaning | 1.64717887 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.61505384 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 1.60750048 |
| 35 | MP0004130_abnormal_muscle_cell | 1.59376342 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.56612605 |
| 37 | MP0000955_abnormal_spinal_cord | 1.47343540 |
| 38 | MP0005503_abnormal_tendon_morphology | 1.47316674 |
| 39 | MP0003122_maternal_imprinting | 1.38547137 |
| 40 | MP0001984_abnormal_olfaction | 1.37801101 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.37402858 |
| 42 | MP0002066_abnormal_motor_capabilities/c | 1.34187749 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.34136240 |
| 44 | MP0001905_abnormal_dopamine_level | 1.31391072 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.30965826 |
| 46 | MP0005167_abnormal_blood-brain_barrier | 1.30294767 |
| 47 | MP0003879_abnormal_hair_cell | 1.30245057 |
| 48 | MP0001188_hyperpigmentation | 1.29957682 |
| 49 | MP0003279_aneurysm | 1.29662436 |
| 50 | MP0003633_abnormal_nervous_system | 1.28520727 |
| 51 | MP0003283_abnormal_digestive_organ | 1.28432913 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.26240469 |
| 53 | MP0003787_abnormal_imprinting | 1.22279755 |
| 54 | MP0000749_muscle_degeneration | 1.20327289 |
| 55 | MP0001958_emphysema | 1.18974989 |
| 56 | MP0001529_abnormal_vocalization | 1.15729106 |
| 57 | MP0004215_abnormal_myocardial_fiber | 1.14843902 |
| 58 | MP0000751_myopathy | 1.14651142 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.14360354 |
| 60 | MP0004142_abnormal_muscle_tone | 1.11466542 |
| 61 | MP0003631_nervous_system_phenotype | 1.10707785 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.06584148 |
| 63 | MP0003075_altered_response_to | 1.06476207 |
| 64 | MP0004885_abnormal_endolymph | 1.05466556 |
| 65 | MP0002152_abnormal_brain_morphology | 1.03766727 |
| 66 | MP0003705_abnormal_hypodermis_morpholog | 1.03300672 |
| 67 | MP0005409_darkened_coat_color | 1.00925309 |
| 68 | MP0003690_abnormal_glial_cell | 1.00612701 |
| 69 | MP0002332_abnormal_exercise_endurance | 0.98641028 |
| 70 | MP0004742_abnormal_vestibular_system | 0.97845432 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 0.97247263 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 0.96567185 |
| 73 | MP0004036_abnormal_muscle_relaxation | 0.94349745 |
| 74 | MP0004145_abnormal_muscle_electrophysio | 0.93685092 |
| 75 | MP0004085_abnormal_heartbeat | 0.93153101 |
| 76 | MP0000534_abnormal_ureter_morphology | 0.91698875 |
| 77 | MP0004272_abnormal_basement_membrane | 0.90886107 |
| 78 | MP0004484_altered_response_of | 0.88423752 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.88216277 |
| 80 | MP0002229_neurodegeneration | 0.87871886 |
| 81 | MP0001542_abnormal_bone_strength | 0.85763022 |
| 82 | MP0003634_abnormal_glial_cell | 0.84524947 |
| 83 | MP0005171_absent_coat_pigmentation | 0.82686647 |
| 84 | MP0001963_abnormal_hearing_physiology | 0.82282642 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.80380388 |
| 86 | MP0005535_abnormal_body_temperature | 0.77157813 |
| 87 | MP0003632_abnormal_nervous_system | 0.76562883 |
| 88 | MP0000759_abnormal_skeletal_muscle | 0.76223831 |
| 89 | MP0008872_abnormal_physiological_respon | 0.75844343 |
| 90 | MP0002752_abnormal_somatic_nervous | 0.75741417 |
| 91 | MP0005388_respiratory_system_phenotype | 0.75518067 |
| 92 | MP0002133_abnormal_respiratory_system | 0.75518067 |
| 93 | MP0008874_decreased_physiological_sensi | 0.75297285 |
| 94 | MP0000604_amyloidosis | 0.74530086 |
| 95 | MP0005275_abnormal_skin_tensile | 0.74414292 |
| 96 | MP0002108_abnormal_muscle_morphology | 0.73166120 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.73103321 |
| 98 | MP0001177_atelectasis | 0.73031221 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.73029508 |
| 100 | MP0003045_fibrosis | 0.72240934 |
| 101 | MP0004084_abnormal_cardiac_muscle | 0.71955185 |
| 102 | MP0005187_abnormal_penis_morphology | 0.70252021 |
| 103 | MP0003091_abnormal_cell_migration | 0.69861347 |
| 104 | MP0002090_abnormal_vision | 0.69539995 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.68485916 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.68464077 |
| 107 | MP0003123_paternal_imprinting | 0.68334951 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.66737118 |
| 109 | MP0005499_abnormal_olfactory_system | 0.65886960 |
| 110 | MP0005394_taste/olfaction_phenotype | 0.65886960 |
| 111 | MP0004087_abnormal_muscle_fiber | 0.65326857 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.64985887 |
| 113 | MP0000747_muscle_weakness | 0.64237110 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.63802651 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.63493669 |
| 116 | MP0006138_congestive_heart_failure | 0.63181190 |
| 117 | MP0001879_abnormal_lymphatic_vessel | 0.62561431 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 0.62060512 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.60484886 |
| 120 | MP0000920_abnormal_myelination | 0.60219182 |
| 121 | MP0006072_abnormal_retinal_apoptosis | 0.60021087 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.58986386 |
| 123 | MP0001485_abnormal_pinna_reflex | 0.58887751 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.56571957 |
| 125 | MP0001943_abnormal_respiration | 0.55421237 |
| 126 | MP0010368_abnormal_lymphatic_system | 0.54113381 |
| 127 | MP0001664_abnormal_digestion | 0.52764036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.65137621 |
| 2 | Myokymia (HP:0002411) | 6.23439609 |
| 3 | Focal seizures (HP:0007359) | 5.81882220 |
| 4 | Visual hallucinations (HP:0002367) | 4.96234528 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.84399678 |
| 6 | Atonic seizures (HP:0010819) | 4.64771191 |
| 7 | Febrile seizures (HP:0002373) | 4.40805971 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.24259807 |
| 9 | Absence seizures (HP:0002121) | 3.99982676 |
| 10 | Dialeptic seizures (HP:0011146) | 3.87622320 |
| 11 | Broad-based gait (HP:0002136) | 3.80081475 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.75641274 |
| 13 | Hyperventilation (HP:0002883) | 3.73913666 |
| 14 | Action tremor (HP:0002345) | 3.38874716 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.37885475 |
| 16 | Dysmetria (HP:0001310) | 3.16469952 |
| 17 | Mutism (HP:0002300) | 3.16117770 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.09088385 |
| 19 | Abnormal eating behavior (HP:0100738) | 3.08063561 |
| 20 | Amblyopia (HP:0000646) | 3.01749914 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.00973177 |
| 22 | Excessive salivation (HP:0003781) | 2.97617574 |
| 23 | Drooling (HP:0002307) | 2.97617574 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.97379345 |
| 25 | Ankle clonus (HP:0011448) | 2.94849833 |
| 26 | Truncal ataxia (HP:0002078) | 2.92062320 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 2.88709678 |
| 28 | Anxiety (HP:0000739) | 2.84838369 |
| 29 | Hemiparesis (HP:0001269) | 2.84191826 |
| 30 | Depression (HP:0000716) | 2.81665981 |
| 31 | Poor eye contact (HP:0000817) | 2.81540643 |
| 32 | Progressive inability to walk (HP:0002505) | 2.78569577 |
| 33 | Protrusio acetabuli (HP:0003179) | 2.76603632 |
| 34 | Rigidity (HP:0002063) | 2.76209357 |
| 35 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.70975620 |
| 36 | Hypokinesia (HP:0002375) | 2.70182692 |
| 37 | Fetal akinesia sequence (HP:0001989) | 2.65208737 |
| 38 | Abnormality of binocular vision (HP:0011514) | 2.64287911 |
| 39 | Diplopia (HP:0000651) | 2.64287911 |
| 40 | Diminished movement (HP:0002374) | 2.63813865 |
| 41 | Vascular tortuosity (HP:0004948) | 2.55959426 |
| 42 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.55511277 |
| 43 | Limb dystonia (HP:0002451) | 2.50858578 |
| 44 | Abnormal social behavior (HP:0012433) | 2.50410181 |
| 45 | Impaired social interactions (HP:0000735) | 2.50410181 |
| 46 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.49455683 |
| 47 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.48174950 |
| 48 | Delayed gross motor development (HP:0002194) | 2.47109879 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.46863475 |
| 50 | Lower limb muscle weakness (HP:0007340) | 2.45297140 |
| 51 | Abnormality of salivation (HP:0100755) | 2.43725960 |
| 52 | Polyphagia (HP:0002591) | 2.41154906 |
| 53 | Inability to walk (HP:0002540) | 2.40999718 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.40534173 |
| 55 | Postural instability (HP:0002172) | 2.40509502 |
| 56 | Absent speech (HP:0001344) | 2.39079787 |
| 57 | Arterial tortuosity (HP:0005116) | 2.39011670 |
| 58 | Urinary urgency (HP:0000012) | 2.38502710 |
| 59 | Genetic anticipation (HP:0003743) | 2.36151205 |
| 60 | Papilledema (HP:0001085) | 2.35638956 |
| 61 | Scanning speech (HP:0002168) | 2.34547411 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.33521513 |
| 63 | Incomplete penetrance (HP:0003829) | 2.31598161 |
| 64 | Termporal pattern (HP:0011008) | 2.31118513 |
| 65 | Insidious onset (HP:0003587) | 2.31118513 |
| 66 | Hemiplegia (HP:0002301) | 2.30629211 |
| 67 | Mask-like facies (HP:0000298) | 2.30325359 |
| 68 | Lower limb amyotrophy (HP:0007210) | 2.29141382 |
| 69 | Abnormality of the corticospinal tract (HP:0002492) | 2.27419781 |
| 70 | Stereotypic behavior (HP:0000733) | 2.25712297 |
| 71 | Aortic aneurysm (HP:0004942) | 2.24572821 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.21765046 |
| 73 | Bundle branch block (HP:0011710) | 2.20553269 |
| 74 | Myotonia (HP:0002486) | 2.18193267 |
| 75 | Broad metatarsal (HP:0001783) | 2.18009177 |
| 76 | Impaired smooth pursuit (HP:0007772) | 2.15794122 |
| 77 | Bradykinesia (HP:0002067) | 2.14529558 |
| 78 | Pheochromocytoma (HP:0002666) | 2.13603814 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.13022593 |
| 80 | Torticollis (HP:0000473) | 2.12632721 |
| 81 | Type 1 muscle fiber predominance (HP:0003803) | 2.10948591 |
| 82 | Hypsarrhythmia (HP:0002521) | 2.09376777 |
| 83 | Overgrowth (HP:0001548) | 2.09286548 |
| 84 | Gait ataxia (HP:0002066) | 2.08647139 |
| 85 | Premature rupture of membranes (HP:0001788) | 2.08213444 |
| 86 | Blue irides (HP:0000635) | 2.06925588 |
| 87 | Megalencephaly (HP:0001355) | 2.06855857 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 2.05830744 |
| 89 | Generalized myoclonic seizures (HP:0002123) | 2.05063539 |
| 90 | Akinesia (HP:0002304) | 2.04502072 |
| 91 | Spastic gait (HP:0002064) | 2.04104840 |
| 92 | Spinal rigidity (HP:0003306) | 2.02740327 |
| 93 | Status epilepticus (HP:0002133) | 2.02738622 |
| 94 | Clonus (HP:0002169) | 2.02006549 |
| 95 | Focal dystonia (HP:0004373) | 2.01375688 |
| 96 | Ventricular fibrillation (HP:0001663) | 1.99215399 |
| 97 | Intention tremor (HP:0002080) | 1.98696708 |
| 98 | Prolonged QT interval (HP:0001657) | 1.98530603 |
| 99 | Protruding tongue (HP:0010808) | 1.92978075 |
| 100 | Gait imbalance (HP:0002141) | 1.90212655 |
| 101 | Rapidly progressive (HP:0003678) | 1.89818278 |
| 102 | Agitation (HP:0000713) | 1.89000161 |
| 103 | Abnormal EKG (HP:0003115) | 1.88967567 |
| 104 | Shallow orbits (HP:0000586) | 1.85858563 |
| 105 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.84388969 |
| 106 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82928600 |
| 107 | Annular pancreas (HP:0001734) | 1.82788994 |
| 108 | Specific learning disability (HP:0001328) | 1.82535930 |
| 109 | Impaired vibratory sensation (HP:0002495) | 1.82359046 |
| 110 | Exotropia (HP:0000577) | 1.82240449 |
| 111 | Neuronal loss in central nervous system (HP:0002529) | 1.80923216 |
| 112 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.80729979 |
| 113 | Hypoplasia of the brainstem (HP:0002365) | 1.80729979 |
| 114 | Sleep apnea (HP:0010535) | 1.80650240 |
| 115 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80581087 |
| 116 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80581087 |
| 117 | Aplasia involving bones of the extremities (HP:0009825) | 1.80581087 |
| 118 | Dyskinesia (HP:0100660) | 1.79929206 |
| 119 | Neuroendocrine neoplasm (HP:0100634) | 1.78969220 |
| 120 | Bradycardia (HP:0001662) | 1.78866618 |
| 121 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78861753 |
| 122 | Psychosis (HP:0000709) | 1.77490697 |
| 123 | Absent/shortened dynein arms (HP:0200106) | 1.76437257 |
| 124 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.76437257 |
| 125 | Hypoventilation (HP:0002791) | 1.76281718 |
| 126 | Inappropriate behavior (HP:0000719) | 1.75637647 |
| 127 | Craniofacial dystonia (HP:0012179) | 1.75424571 |
| 128 | Sudden death (HP:0001699) | 1.69167121 |
| 129 | Dysmetric saccades (HP:0000641) | 1.69110019 |
| 130 | Coronal craniosynostosis (HP:0004440) | 1.67621848 |
| 131 | Spastic tetraparesis (HP:0001285) | 1.65873900 |
| 132 | Tetraplegia (HP:0002445) | 1.65069123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.87329666 |
| 2 | EPHA4 | 4.15255589 |
| 3 | MAP3K9 | 3.75860953 |
| 4 | MARK1 | 3.42015505 |
| 5 | CASK | 2.90867284 |
| 6 | MAP3K4 | 2.59411792 |
| 7 | MINK1 | 2.54100484 |
| 8 | TNIK | 2.40255782 |
| 9 | MAP3K12 | 2.31940771 |
| 10 | NTRK2 | 2.30416153 |
| 11 | MAP2K7 | 2.27741348 |
| 12 | PAK6 | 2.02838987 |
| 13 | DAPK2 | 1.99030256 |
| 14 | KSR2 | 1.98494370 |
| 15 | PRPF4B | 1.87368441 |
| 16 | MAPKAPK5 | 1.74435897 |
| 17 | MAP2K4 | 1.69288747 |
| 18 | MAPK13 | 1.67751049 |
| 19 | KSR1 | 1.67042058 |
| 20 | RIPK1 | 1.60053406 |
| 21 | GRK5 | 1.51679847 |
| 22 | PLK2 | 1.48161176 |
| 23 | PHKG2 | 1.47302598 |
| 24 | PHKG1 | 1.47302598 |
| 25 | PNCK | 1.45107665 |
| 26 | CDK5 | 1.44749470 |
| 27 | NTRK1 | 1.44393682 |
| 28 | DAPK1 | 1.40535518 |
| 29 | MAP3K13 | 1.39628743 |
| 30 | PRKD3 | 1.38887792 |
| 31 | FES | 1.37588725 |
| 32 | RIPK4 | 1.35198112 |
| 33 | PTK2B | 1.31834132 |
| 34 | ARAF | 1.26928504 |
| 35 | CAMKK1 | 1.24370294 |
| 36 | SIK2 | 1.23475592 |
| 37 | PRKCG | 1.16441118 |
| 38 | LATS2 | 1.11600323 |
| 39 | CAMK2A | 1.07141181 |
| 40 | PAK3 | 1.01295125 |
| 41 | SIK3 | 0.93608255 |
| 42 | CAMK1 | 0.92192193 |
| 43 | MAP3K11 | 0.91813283 |
| 44 | MYLK | 0.91476260 |
| 45 | CAMK2B | 0.90771702 |
| 46 | STK38 | 0.88140925 |
| 47 | UHMK1 | 0.87654094 |
| 48 | GRK7 | 0.86654883 |
| 49 | CDK19 | 0.86382164 |
| 50 | MARK2 | 0.86162729 |
| 51 | LIMK1 | 0.85995503 |
| 52 | FER | 0.85206470 |
| 53 | LMTK2 | 0.84904509 |
| 54 | DDR2 | 0.82766924 |
| 55 | TIE1 | 0.82641301 |
| 56 | SGK494 | 0.82071337 |
| 57 | SGK223 | 0.82071337 |
| 58 | CAMKK2 | 0.79153096 |
| 59 | NEK9 | 0.78777859 |
| 60 | CSNK1G2 | 0.75205379 |
| 61 | CDK18 | 0.74835535 |
| 62 | CDK14 | 0.73859695 |
| 63 | STK11 | 0.72820361 |
| 64 | MAP3K2 | 0.72255530 |
| 65 | PDGFRA | 0.72118186 |
| 66 | PTK2 | 0.71415450 |
| 67 | SGK2 | 0.70897967 |
| 68 | OBSCN | 0.70865418 |
| 69 | CDK15 | 0.70387198 |
| 70 | TYRO3 | 0.67897919 |
| 71 | ROCK2 | 0.64246092 |
| 72 | ROCK1 | 0.63254919 |
| 73 | DYRK1A | 0.62705703 |
| 74 | PRKCE | 0.62338885 |
| 75 | PRKCH | 0.61859814 |
| 76 | MUSK | 0.60500695 |
| 77 | BCR | 0.60370615 |
| 78 | SGK1 | 0.60205779 |
| 79 | RAF1 | 0.60044049 |
| 80 | CDK11A | 0.59130211 |
| 81 | OXSR1 | 0.58807594 |
| 82 | TTN | 0.57183749 |
| 83 | PAK2 | 0.55875758 |
| 84 | RET | 0.54627322 |
| 85 | AKT3 | 0.54581703 |
| 86 | BMPR2 | 0.53285190 |
| 87 | ERBB3 | 0.52969322 |
| 88 | PKN1 | 0.52393373 |
| 89 | CAMK2D | 0.52227712 |
| 90 | NME1 | 0.52059011 |
| 91 | MAPK12 | 0.51770321 |
| 92 | ICK | 0.50997138 |
| 93 | FGR | 0.50182662 |
| 94 | BRAF | 0.49698092 |
| 95 | MAP3K1 | 0.49559930 |
| 96 | CSNK1G3 | 0.49053453 |
| 97 | CAMK1G | 0.48499444 |
| 98 | MAP2K1 | 0.48373684 |
| 99 | EEF2K | 0.47138178 |
| 100 | TAOK2 | 0.46489031 |
| 101 | CAMK2G | 0.46028618 |
| 102 | SGK3 | 0.45921522 |
| 103 | PKN2 | 0.45482913 |
| 104 | RPS6KA3 | 0.44053894 |
| 105 | FYN | 0.44011769 |
| 106 | PINK1 | 0.43016523 |
| 107 | PRKCZ | 0.42000203 |
| 108 | PDPK1 | 0.41647190 |
| 109 | DAPK3 | 0.40455177 |
| 110 | TESK1 | 0.39786640 |
| 111 | WNK1 | 0.39782875 |
| 112 | MAP3K7 | 0.38449542 |
| 113 | MAPK4 | 0.38161957 |
| 114 | PRKD2 | 0.37802399 |
| 115 | MAPK10 | 0.37443490 |
| 116 | PDK1 | 0.36772700 |
| 117 | CAMK4 | 0.36171786 |
| 118 | TRIB3 | 0.34946185 |
| 119 | CDC42BPA | 0.34650091 |
| 120 | RPS6KA2 | 0.33336883 |
| 121 | STK39 | 0.31517288 |
| 122 | PRKG1 | 0.30925662 |
| 123 | MOS | 0.30706696 |
| 124 | PRKACA | 0.30612852 |
| 125 | ADRBK1 | 0.30069823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.85809913 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.07644004 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70348630 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.64845396 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.62932918 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62563827 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60634615 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.52548221 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.42591964 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42474177 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04348761 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.04153521 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02772227 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.94042273 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.87606381 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.81311532 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81060006 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.77286637 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74898953 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.72870349 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.70034158 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66700651 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66539011 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66329335 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55000552 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.51611693 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51545018 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48196913 |
| 29 | Axon guidance_Homo sapiens_hsa04360 | 1.41341371 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.36252647 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32684871 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28326866 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26323643 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23754771 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22634130 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14777000 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14438961 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.05923163 |
| 39 | Melanogenesis_Homo sapiens_hsa04916 | 1.04863975 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03883831 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03195630 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02414700 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.02075883 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00238087 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97949978 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95248650 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94897252 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92917445 |
| 49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91115898 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86230725 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83332737 |
| 52 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82789515 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.81838635 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.77973036 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77962911 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77325177 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.75629126 |
| 58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75188596 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74258331 |
| 60 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73041264 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71800346 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70500935 |
| 63 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70369367 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68862639 |
| 65 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68196932 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65738543 |
| 67 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65202399 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62791387 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62628938 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61168541 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60566472 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59314323 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58301962 |
| 74 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56103725 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56039293 |
| 76 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54196887 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.54107001 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53259252 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52475481 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51477872 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51323505 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50594699 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.49841212 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48821053 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45133081 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45019023 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44639046 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43693073 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.43564967 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42427505 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42419546 |
| 92 | Parkinsons disease_Homo sapiens_hsa05012 | 0.42283610 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42202822 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41912275 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41700638 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.41048439 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41002471 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.39722663 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39081184 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.38119684 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36797076 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35451388 |
| 103 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.35325451 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34449944 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.34118650 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.34072882 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33752291 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33204062 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27515924 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.27508448 |
| 111 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.27229144 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26534995 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.25370035 |

